Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Jun 13, 2020

30198_dirs_2020-06-12_89e21921-850c-48d9-a3eb-addeeac7d0ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-06-10

Reporting Person: Selvaraj Shelly Ramasamy (SVP Information Technology)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-10 Common Stock S 400 $385.22 Disposed 22841 Direct

Footnotes

F1: On May 30, 2019, Mr. Selvaraj adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Selvaraj. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: Included in this number are 16,896 unvested restricted stock units, 5,483 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,512 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,901 of which were granted on March 8, 2018 and shall vest through March 8, 2021.